Du är här


Navamedic ASA : Approved Information Memorandum

Reference is made to the stock exchange notice dated 4 August 2015 regarding
Navamedic ASA's acquisition of 100% of the shares in Observe Medical
International AB (OM) (the "Transaction").

The attached Information Memorandum has been prepared by Navamedic ASA in
order to provide information about the Company and its business in connection
with the purchase of OM.

Oslo Stock Exchange has approved the Information Memorandum dated 14 September

The Information Memorandum does not constitute an offer to sell, or a
solicitation of an offer to buy, any of the shares or other securities issued
by Navamedic ASA.

The Information Memorandum is enclosed hereto and will also be available at
the Company's website: www.navamedic.com

For further information, please contact Bjørn Lindholt, CFO Navamedic
ASA,bjorn.lindholt@navamedic.com, tel. +47 930 06 601.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

Navamedic Information Memorandum


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.